Product Code: RP-ID-10352435 |
Published Date: 21 Mar 2025 |
Region: Global |
Category: ICT & Telecom |
Report ID: 10352435
Market Overview:
Sexually Transmitted Disease Testing Market Analysis by Disease (Human Immunodeficiency Virus, Herpes Simplex Virus, Human Papillomavirus, Chlamydia, Syphilis, Gonorrhea, Cancroid and Others); by Location (Laboratory, and Point of Care); and by Device (Laboratory Devices, and Point of Care Devices)-Global Supply & Demand Analysis & Opportunity Outlook 2023-2033
Sexually Transmitted Disease Testing Market Scope
|
Base Year |
2022 |
|
Forecast Year |
2023-2033 |
|
CAGR |
~6% |
|
Base Year Market Size (2023) |
~ USD 95,000 Million |
|
Forecast Year Market Size (2033) |
~ USD 145,000 Million |
Global Sexually Transmitted Disease Testing Market Highlights Over 2023 - 2033
The global sexually transmitted disease testing market is estimated to garner a revenue of USD 145,000Million by the end of 2033 by growing at a CAGR of ~6% over the forecast period, i.e., 2023 – 2033. Further, the market generated a revenue of USD 95,000 Million in the year 2022. Higher instances of sexually transmitted disease (STD) in younger people is expected to drive the market growth. The adults of 15-24 years old holds the share of up to 50% of all new STD’s. Additionally, every 1 in 4 teens gets infected by STD every year.
GET A SAMPLE COPY OF THIS REPORT
Increasing sexual crimes against women is to propel the growth of the transmission of sexually transmitted infection among the women. According to the United Nations, 736 million women, at-least once in their lifetime have been gone through sexual intimate partner violence, non-partner violence or both. Furthermore, higher number of people working as sex workers, insurance covering the treatment of STD and increased case of STD is to propel the growth of global sexually transmitted disease testing market.
Global Sexually Transmitted Disease Testing Market: Growth Drivers and Challenges
Growth Drivers
-
Rising Cases of Sexually Transmitted Disease (STD)
Cases of sexually transmitted is rising owing to people active sexual life, choices of multiple partners and not using contraceptives. According to the World Health Organization (WHO), over 1 million sexually transmitted infections are transmitted all across the world.
-
Reimbursement Policy for Given for STD Testing and Treatment
Many countries are offering insurance or some sort of reimbursement to people. In 2019, the UPSTSTF task force added a full coverage of STDs in insurance plan.
-
Alarming Rise in Number of Rape Cases and Sexual Harassment
With the increasing rape crimes, the cases of sexually transmitted cases are also rising. According to the WHO, every 1 in 3 women experience sexual violence at-least once in their lifetime.
-
Growing Prostitution Across the World
Lack of enforcement by the law, increased human trafficking, is leading to growth of prostitution and more people involving into prostitution. Nearly, 40-42 million prostitutes are present worldwide, moreover, over 80% of global prostitute population are females.
-
Rise in Global Population of Young Adults
Young adults are socially more active, their broadened mentality leads them to get engage sexually with more partners, therefore, they are more susceptible to STD. By the statistics of the WHO, one in 20 young people catches STD each year. The rate is higher among the age group of 20-24 years.
Challenges
-
Social Stigma Associated with Sexually Transmitted Diseases
-
High Cost of Systems Required for STD Detection
-
Lack of Accurate Result by Detection Systems
Sexually transmitted disease is proven to be common disease, but the social stigma surrounding STDs still exists. Even after rise in educated population, people have false notion about sex or sex related problems. There is huge share of population, who hesitates to talk about sex or go for STD testing and treatment. Therefore, the rising social stigma is to hinder the market growth.
The sexually transmitted disease testing market is segmented and analyzed for demand and supply by disease into human immunodeficiency virus, herpes simplex virus, human papillomavirus, chlamydia, syphilis, gonorrhea, cancroid and others. Out of these, the chlamydia segment is to garner highest revenue by the end of 2033. Rising cases of chlamydia is to propel the growth of the segment. The center of disease control and prevention reported total 1,808,703 cases of chlamydia in 2019. According to the World Health Organization, in 2020 there were 129 million instances of chlamydia.
Global Sexually Transmitted Disease Testing Market Regional Synopsis
Regionally, the global sexually transmitted disease testing market is studied into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Amongst these markets, the market in Asia Pacific is projected to hold the largest market share by the end of 2033. Rising cases of rape and sexual harassment in the region is increasing the chances of sexually transmitted disease. In 2021, nearly 86 daily rapes and around 50 sexual crimes against women has been reported very hour in India. Moreover, in the Thailand, the population of sex worker is around 250,000 to 2 million. Higher cases reported of sexually transmitted disease. In 2021, over 20,000 deaths were caused by STD in China, and nearly 20 thousand people died of AIDS.
Market Segmentation
Our in-depth analysis of the global sexually transmitted disease testing market includes the following segments:
|
By Disease |
|
|
By Location |
|
|
By Device |
|
Customize this Report: Request Customization
Key Companies Dominating the Global Sexually Transmitted Disease Testing Market
Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global sexually transmitted disease testing market that are included in our report are F. Hoffmann-La Roche Ltd., Abbott, bioMerieux, Becton Dickinson and Company, Quest Diagnostics, Thermo Fisher Scientific, Hologic Inc., Orasure Technologies, Inc., S&P Global, DiaSorin Molecular LLC., and others.
Global Sexually Transmitted Disease Testing Market: Latest Developments
-
March, 2021: Abbott collaborated with Johns Hopkins University, the University of Missouri-Kansas City (UMKC), National Institute of Allergy and Infectious Diseases (NIAID) and the Universite Protestante au Congo (UPC), and discovered a set of rare HIV carriers in the patient with no sign of symptoms.
-
April, 2019: Quest Diagnostics has launched three new sexually transmitted disease laboratory test packages. They are available online for consumers and are user-friendly.
Key Reasons to Buy Our Report
-
The report covers detailed analysis comprising market share attained by each market segment and its sub-segments.
-
It covers market dynamics including growth drivers, trends, potential opportunities, price trend analysis and challenges that impact the market growth.
-
The report includes detailed company profiles of the major players dominating the market.
-
We use effective research methodologies to calculate the market numbers and provide value-added assessment for overall growth.
-
We provide customized reports as per the clients’ requirement helping them to see possible and unexpected challenges and unforeseen opportunities in order to help them reach their goal.
- F. Hoffmann-La Roche Ltd.
- Abbott
- bioMerieux
- Becton Dickinson and Company
- Quest Diagnostics
- Thermo Fisher Scientific
- Hologic Inc.
- Orasure Technologies Inc.
- S&P Global
- DiaSorin Molecular LLC.
Related Reports
Proof of Quality & Reliability
